Author

Jessica Nardulli

Icahn School of Medicine at Mount SinaiORCID 0009-0002-5309-5413Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Assay:proteomics· 1

Frequent Co-Authors

Florian KrammeriD· 2 shared Alesandro CivljakiD· 1 shared Ana Gonzalez-Reiche· 1 shared Bailey Bozarth· 1 shared Brian C Monahan· 1 shared Brian MonahaniD· 1 shared Camila H. CoelhoiD· 1 shared Charles GleasoniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Florian KrammerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintOct 28, 2026

N1 neuraminidase monoclonal antibodies 2H08 and 3H03 have decreased binding and inhibition properties against H1N1 influenza viruses circulating after 2018

Disha Bhavsar, Enikő Hermann, Brian Monahan…·Florian Krammer

The paper shows that two N1 neuraminidase monoclonal antibodies lose activity against recent H1N1 influenza viruses due to changes in electrostatic surface potential, but remain active against H5N1.

DOI 10.64898/2026.10.26.761829

humanexperimental assay

𝕏 PostBluesky

ImmunologyThe Lancet MicrobePeer-reviewedMay 30, 2025

Dissecting human monoclonal antibody responses from mRNA- and protein-based XBB.1.5 COVID-19 monovalent vaccines

Raianna Farhat Fantin, Jordan J. Clark, Hallie Cohn…·Camila H. Coelho

This study evaluates monoclonal antibody responses to XBB.1.5 vaccines by analyzing plasmablasts from vaccinated individuals and characterizing their binding and neutralization properties against SARS-CoV-2 variants.

10 citationstop 3%

humanproteomics

𝕏 PostBluesky